452 related articles for article (PubMed ID: 25141979)
1. The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach.
Salahuddin P; Rabbani G; Khan RH
Cell Mol Biol Lett; 2014 Sep; 19(3):407-37. PubMed ID: 25141979
[TBL] [Abstract][Full Text] [Related]
2. The sour side of neurodegenerative disorders: the effects of protein glycation.
Vicente Miranda H; Outeiro TF
J Pathol; 2010 May; 221(1):13-25. PubMed ID: 20186922
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Methodologies to Study the Role of Advanced Glycation End Products (AGEs) in Neurodegeneration.
Chrysanthou M; Miro Estruch I; Rietjens IMCM; Wichers HJ; Hoppenbrouwers T
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057544
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective.
Li J; Liu D; Sun L; Lu Y; Zhang Z
J Neurol Sci; 2012 Jun; 317(1-2):1-5. PubMed ID: 22410257
[TBL] [Abstract][Full Text] [Related]
5. A review on prevention of glycation of proteins: Potential therapeutic substances to mitigate the severity of diabetes complications.
Sarmah S; Roy AS
Int J Biol Macromol; 2022 Jan; 195():565-588. PubMed ID: 34920073
[TBL] [Abstract][Full Text] [Related]
6. DNA-aptamers raised against AGEs as a blocker of various aging-related disorders.
Yamagishi S; Taguchi K; Fukami K
Glycoconj J; 2016 Aug; 33(4):683-90. PubMed ID: 27338620
[TBL] [Abstract][Full Text] [Related]
7. Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson's Disease.
König A; Vicente Miranda H; Outeiro TF
J Parkinsons Dis; 2018; 8(1):33-43. PubMed ID: 29480231
[TBL] [Abstract][Full Text] [Related]
8. Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions.
Koerich S; Parreira GM; de Almeida DL; Vieira RP; de Oliveira ACP
Curr Neuropharmacol; 2023; 21(2):219-234. PubMed ID: 36154605
[TBL] [Abstract][Full Text] [Related]
9. Glycation vs. glycosylation: a tale of two different chemistries and biology in Alzheimer's disease.
Taniguchi N; Takahashi M; Kizuka Y; Kitazume S; Shuvaev VV; Ookawara T; Furuta A
Glycoconj J; 2016 Aug; 33(4):487-97. PubMed ID: 27325408
[TBL] [Abstract][Full Text] [Related]
10. Impact of Non-Enzymatic Glycation in Neurodegenerative Diseases: Role of Natural Products in Prevention.
Ahmad S; Farhan M
Adv Neurobiol; 2016; 12():125-51. PubMed ID: 27651252
[TBL] [Abstract][Full Text] [Related]
11. The Role of Glyoxalase in Glycation and Carbonyl Stress Induced Metabolic Disorders.
Saeed M; Kausar MA; Singh R; Siddiqui AJ; Akhter A
Curr Protein Pept Sci; 2020; 21(9):846-859. PubMed ID: 32368974
[TBL] [Abstract][Full Text] [Related]
12. Metals, oxidative stress and neurodegenerative disorders.
Jomova K; Vondrakova D; Lawson M; Valko M
Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease.
Guerrero E; Vasudevaraju P; Hegde ML; Britton GB; Rao KS
Mol Neurobiol; 2013 Apr; 47(2):525-36. PubMed ID: 22923367
[TBL] [Abstract][Full Text] [Related]
14. In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways.
Booth AA; Khalifah RG; Todd P; Hudson BG
J Biol Chem; 1997 Feb; 272(9):5430-7. PubMed ID: 9038143
[TBL] [Abstract][Full Text] [Related]
15. Copper, Iron, Selenium and Lipo-Glycemic Dysmetabolism in Alzheimer's Disease.
Aaseth J; Skalny AV; Roos PM; Alexander J; Aschner M; Tinkov AA
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502369
[TBL] [Abstract][Full Text] [Related]
16. Glycation in Parkinson's disease and Alzheimer's disease.
Vicente Miranda H; El-Agnaf OM; Outeiro TF
Mov Disord; 2016 Jun; 31(6):782-90. PubMed ID: 26946341
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products (AGEs), protein aggregation and their cross talk: new insight in tumorigenesis.
Haque E; Kamil M; Hasan A; Irfan S; Sheikh S; Khatoon A; Nazir A; Mir SS
Glycobiology; 2019 Dec; 30(1):49-57. PubMed ID: 31508802
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
[TBL] [Abstract][Full Text] [Related]
19. D-ribose and pathogenesis of Alzheimer's disease.
Javed M; Ahmad MI; Javed H; Naseem S
Mol Biol Rep; 2020 Mar; 47(3):2289-2299. PubMed ID: 31933261
[TBL] [Abstract][Full Text] [Related]
20. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
